a15 Pill - purple capsule/oblong, 14mm
Generic Name: upadacitinib
Pill with imprint a15 is Purple, Capsule/Oblong and has been identified as Rinvoq 15 mg. It is supplied by AbbVie Inc.
Rinvoq is used in the treatment of Crohn's Disease; Ankylosing Spondylitis; Atopic Dermatitis; Non-Radiographic Axial Spondyloarthritis; Polyarticular Juvenile Idiopathic Arthritis and belongs to the drug class antirheumatics. Rinvoq 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for a15
Rinvoq
- Generic Name
- upadacitinib
- Imprint
- a15
- Strength
- 15 mg
- Color
- Purple
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antirheumatics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AbbVie Inc.
- National Drug Code (NDC)
- 00074-2306
Related images for "a15"
More about Rinvoq (upadacitinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (170)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antirheumatics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
